0560439 - FGÚ 2023 RIV CH eng J - Journal Article
Malínská, H. - Hüttl, M. - Marková, I. - Miklánková, D. - Hojná, Silvie - Papoušek, František - Šilhavý, Jan - Mlejnek, Petr - Zicha, Josef - Hrdlička, Jaroslav - Pravenec, Michal - Vaněčková, Ivana
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.
Biomedicines. Roč. 10, č. 9 (2022), č. článku 2066. E-ISSN 2227-9059
R&D Projects: GA ČR(CZ) GA19-06199S; GA MŠMT(CZ) LX22NPO5104
Institutional support: RVO:67985823
Keywords : SHR-CRP * SGLT-2 inhibitor * gene expression * age * lipid metabolism
OECD category: Physiology (including cytology)
Impact factor: 4.7, year: 2022 ; AIS: 0.804, rok: 2022
Method of publishing: Open access
Result website:
https://www.mdpi.com/2227-9059/10/9/2066DOI: https://doi.org/10.3390/biomedicines10092066
Permanent Link: https://hdl.handle.net/11104/0333368